Michael Doubek
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
- Genetics 90
- Chronic Lymphocytic Leukemia Research 78
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Hematology 49
- Chronic Myeloid Leukemia Treatments 22
- Acute Myeloid Leukemia Research 16
- Hematopoietic Stem Cell Transplantation 9
- Co-authors
- Jiřı́ Mayer (80 shared papers)Yvona Brychtová (56 shared papers)Šárka Pospı́šilová (72 shared papers)Martin Trbušek (22 shared papers)Boris Tichý (21 shared papers)Karla Plevová (26 shared papers)Jitka Malčíková (19 shared papers)Marek Mráz (14 shared papers)
In The Last Decade
Michael Doubek
157 papers receiving 2.3k citations
Michael Doubek's Hit Papers
Peers
Comparison fields: 5 of 95
- Genetics 977
- Hematology 666
- Pathology and Forensic Medicine 580
- Immunology 440
- Oncology 466
Countries citing papers authored by Michael Doubek
This map shows the geographic impact of Michael Doubek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Doubek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Doubek more than expected).
Fields of papers citing papers by Michael Doubek
This network shows the impact of papers produced by Michael Doubek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Doubek. The network helps show where Michael Doubek may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Doubek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 149 | |
| 2 | 2009 | 134 | |
| 3 | 2014 | 108 | |
| 4 | 2013 | 84 | |
| 5 | 2016 | 84 | |
| 6 | 2011 | 81 | |
| 7 | 2012 | 78 | |
| 8 | 2002 | 68 | |
| 9 | 2017 | 68 | |
| 10 | 2011 | 66 | |
| 11 | 2005 | 64 | |
| 12 | Management of ALL in adults: 2024 ELN recommendations from a European expert panel Hit paper breakdown → | 2024 | 58 |
| 13 | 2015 | 52 | |
| 14 | 2017 | 50 | |
| 15 | 2018 | 46 | |
| 16 | 2009 | 45 | |
| 17 | 2019 | 43 | |
| 18 | 2015 | 42 | |
| 19 | Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel Hit paper breakdown → | 2024 | 40 |
| 20 | 2010 | 39 |
About Michael Doubek
Michael Doubek is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Immunology and Molecular Biology, having authored 169 papers that have together received 2.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (78 papers), Lymphoma Diagnosis and Treatment (39 papers), Acute Lymphoblastic Leukemia research (25 papers), Chronic Myeloid Leukemia Treatments (22 papers), Immunodeficiency and Autoimmune Disorders (22 papers), Acute Myeloid Leukemia Research (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Hematopoietic Stem Cell Transplantation (9 papers). The work is most often cited by research in Genetics (977 citations), Hematology (666 citations), Pathology and Forensic Medicine (580 citations), Immunology (440 citations) and Oncology (466 citations). Michael Doubek has collaborated with scholars based in Czechia, Germany and France. Frequent co-authors include Jiřı́ Mayer, Yvona Brychtová, Šárka Pospı́šilová, Martin Trbušek, Boris Tichý, Karla Plevová, Jitka Malčíková, Marek Mráz, Šárka Pavlová and Jana Kotašková. Their work appears in journals such as Blood, Leukemia, European Journal Of Haematology, Leukemia Research and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.